Retinal ganglion cell (RGC) death is the end result of practically all diseases of the optic nerve, including glaucomatous optic neuropathy. Understanding the factors determining susceptibility of the retina or the optic nerve to glaucomatous damage, and the means to prevent it, requires good animal models. Here we review the different, current models in rodents that have been used to study RGC damage, discuss their value, and their adequacy as models for human glaucoma. Ó
Introduction
Understanding the factors determining susceptibility of the retina or the optic nerve to glaucomatous damage, and the means to prevent it require good animal models. As elevated intraocular pressure (IOP) is considered a primary risk factor for the initiation and progression of glaucomatous optic neuropathy (Leske, 1983) , the current pharmacological therapy for glaucoma relies almost exclusively on drugs that lower IOP. Yet in many cases, in spite of adequate IOP control, damage to the optic nerve continues, as it does in normal tension glaucoma. For these reasons it would be desirable that the next generation of anti-glaucoma agents have neuroprotective effect to prevent or delay the loss of retinal ganglion cells (RGCs) . To discover such agents requires a practical animal model preferably in rodents, because unlike the models for IOP-active drugs (such as the lasered monkey eye), determining RGC survival is terminal for the experimental animal. Additionally, an ideal glaucoma animal model should be easy to maintain in a laboratory environment, be easy to handle, exhibit a predictable onset and clinical course, and the pathology should have a reasonably long time course to mimic that in the human eye (Gelatt, 1977) . Studies carried out over the past two decades have therefore used a variety of possible glaucoma models induced by different mechanisms in rodents. This paper provides a brief review and assessment of the current status of these different rodent glaucoma models by discussing their pros and cons.
Systematics
Medline was used to search the literature from 1966 to the present. Supplemental sources included Index Medicus and references contained in identified articles. Keywords used included RGC, glaucoma, model, rat and mouse. The English abstracts of foreign language articles were used, as well as our personal reference library. A classification system was developed to structure the different current models into acute vs. chronic models and induced vs. spontaneously occurring damage (Table 1) .
One of the main characteristics of glaucoma is the progressive death of RGCs. However ganglion cell death is not exclusive to glaucoma and is found in other retinopathies and optic neuropathies. It is, therefore, relevant to ask what similarities there are between glaucoma and the other optic neuropathies. In addition, it must be determined whether the particular retinal Vision Research 42 (2002) [471] [472] [473] [474] [475] [476] [477] [478] www.elsevier.com/locate/visres pathophysiology or biochemistry of a certain model makes it more appropriately applicable to another human disease.
Crush/axotomy model
Schwartz et al. developed a crush model in which a calibrated and reproducible partial lesion is inflicted on the optic nerve of the adult rat or mouse (Yoles & Schwartz, 1998a) . Using this model, the extent of the primary damage can be quantified and a secondary degeneration demonstrated and assessed. An earlier similar model is the total axotomy of the optic nerve (Barron, Dentinger, Krohel, Easton, & Mankes, 1986; Kikuchi, Tenneti, & Lipton, 2000; Solomon et al., 1996) . Damage inflicted directly on the optic nerve fibers inevitably leads to their degeneration and the eventual death of their cell bodies by apoptosis (Garcia-Valenzuela, Gorczyca, Darzynkiewicz, & Sharma, 1994) . Apoptosis may occur due to lack of neurotrophin supply from the superior colliculus (retrograde death) or may be due to the presence of excessive glutamate or other excitotoxins released in the retina (anterograde death) (Nickells, 1999) . Additionally, over a period of time neurons that initially escaped the injury may undergo a partial and self-perpetuating secondary degeneration, the extent of which is a function of the severity of the primary insult. The proponents of the crush model suggested that a similar mechanism may underlie the spread of damage seen in glaucoma at any given time after the primary cause of the disease has been effectively treated. That might explain why patients with severe pre-existing damage were much more likely to deteriorate even if their IOP was the same or lower than that of patients without visual loss at the time of diagnosis (Duvdevani et al., 1990; Levkovitch-Verbin et al., 2000; Yoles & Schwartz, 1998a,b) . Therefore, the aim of the crush model of the optic nerve was (i) to demonstrate continuing degeneration of the optic nerve after elimination of the primary cause of damage and (ii) to determine whether secondary degeneration is initiated .
This model has been used extensively to study the pathophysiologic degradation of the damaged RGC and its neighboring cells and to test several substances that can inhibit or slow down these apoptotic signal cascades. Using this model it was shown that after injury to the optic nerve, intraocular glutamate and aspartate levels were significantly higher than in normal or sham-operated eyes, but returned to normal after two weeks (Choi, 1992; Sucher, Lipton, & Dreyer, 1997; Yoles & Schwartz, 1998c) . Also using this model the increase in the apoptosis effector enzymes caspase 3 and 9 after axotomy (Kermer et al., 2000; Kermer et al., 1999) and the possibility of reducing the ganglion cell loss with caspase inhibitors was shown (Chaudhary, Ahmed, Quebada, & Sharma, 1999) . The findings that T-cell autoimmunity in the central nervous system might exert, under certain circumstances, a beneficial effect by protecting injured neurons from the spread of damage was demonstrated using this model in rats and in mice (Fisher et al., 2001; Moalem et al., 1999; Moalem et al., 2000) as was the neuroprotective effect of brimonidine (Burke & Schwartz, 1996; Yoles, Wheeler, & Schwartz, 1999) .
The crush model mimics very closely the damage which occurs in traumatic optic neuropathy (TON). TON results from an indirect trauma to the optic nerve due to an impact to the head, causing a partial or complete loss of optic nerve function and, usually, immediate loss of vision. Morphologically an atrophy of the optic nerve becomes visible after 3-4 weeks. These injuries appear to involve both mechanical (primary) and ischemic-induced (secondary) processes that include degeneration of nerve axons, loss of myelin, and rarely optic nerve hemorrhage. Free radicals are produced as a result of the ischemia and hemorrhage, and the evidence of oxy-radical damage, including lipid peroxidation, is compelling (Steinsapir & Goldberg, 1994) . Therefore it seems quite likely to many investigators that the observed loss of ganglion cells in TON occurs in a comparable way to glaucoma, and the crush model could be regarded as a highly acute glaucoma model. (Hayreh & Weingeist, 1980) . However experimental studies of transient (acute) retinal ischemia followed by reperfusion, demonstrated a remarkable tolerance before irreversible damage occurred (Kroll, 1968 ). An extension of this model was the development of a simple non-vascular method to cause ischemia--cannulation of the anterior chamber (AC) with subsequent elevation of the IOP above systolic blood pressure for various periods of time in rats and mice (B€ u uchi, 1992; B€ u uchi, Suivaizdis, & Fu, 1991; Harada et al., 2000; Hughes, 1991 ; Selles-Navarro, Villegas-Perez, Salvador-Silva, Ruiz-Gomez, & VidalSanz, 1996; Stittsworth & Perlman, 2001; Szabo, DroyLefaix, Doly, Carr e e, & Braquet, 1991) . The aim of this model was to mimic the possible chronic hypoxic stress that RGC might undergo in glaucoma. This leads to the shutdown of all energy dependent functions in the RGC with subsequent swelling and distinct disruptions of the mitochondria and degeneration of the neurotubules on the axons (Adachi, Takahashi, Nishikawa, Miki, & Uyama, 1996) . Furthermore it could be shown that the delayed cell death found in this transient ischemic model was not purely necrotic but was caused in part also as a result of apoptosis associated with elevated p53 protein levels within the inner retina (Rosenbaum et al., 1997; Rosenbaum et al., 1998) .
The ischemia/reperfusion model has been used mostly to study damage in RGC. However, because it is not just a specific damage to these cells but a general injury to the whole retina, other neuroscientists use the model to study damage to the outer retina (Kim et al., 1998) . As had already been shown in the crush model, expression of Caspases were also upregulated at the protein and gene levels using this model, giving further evidence for apoptotic mechanisms involved Kurokawa et al., 1999; . Elevated glutamate levels were found in the vitreous (Lagreze, Knorle, Bach, & Feuerstein, 1998; Perlman et al., 1996) and the neuroprotective effect of antagonists of glutamate or its analogues were shown Donello, Padillo, Webster, Wheeler, & Gil, 2001; Kapin, Doshi, Scatton, DeSantis, & Chandler, 1999; Lagreze, Otto, & Feuerstein, 1999; Osborne, 1999; Weber, Bonaventure, & Sahel, 1995) . Furthermore, it was found that the level of inducible nitric oxide synthase (iNOS) mRNA expression was markedly increased in the rat retina following transient ischemia (Hangai, Yoshimura, Hiroi, Mandai, & Honda, 1996) and that inhibition of the enzyme partially abolished the ischemic damage leading to significantly longer survival of RGC (Geyer, Almog, Lupu-Meiri, Lazar, & Oron, 1995; Ju et al., 2000; . Other studies utilizing this model aimed to confirm results showing a neuroprotective effect for brimonidine (Wheeler, Lai, & Woldemussie, 1999) and betaxolol (Osborne, Cazevieille, Carvalho, Larsen, & DeSantis, 1997) .
The ischemia/reperfusion model imitates mostly the type of retinal damage that occurs in CRAO. CRAO is a well-documented condition that can occur after trauma and also embolic, thrombotic, or spasmodic episodes, and causes a selective ischemia to the inner retina. As a result of CRAO, there is extensive edema and subsequent atrophy of the ganglion cell and nerve fiber layers, and severe thinning of the inner nuclear layer. Damage to the outer retina is less prevalent. Visual field defects are extensive, but central vision may be preserved, as a result of cilioretinal sparing of part of the macula. Optic disk cupping is not a recognized consequence to CRAO, although nonglaucomatous cupping has been reported in some patients with CRAO (Trobe, Glaser, & Cassady, 1980) . The biochemical and clinical changes characteristic of CRAO have some similarities to glaucoma but the long-term alterations to the retina cannot be compared between the two diseases.
Excitotoxic damage
Excitatory amino acids (e.g. glutamate, aspartate) are implicated in the pathogenesis of ischemic brain injury. In the ischemia/reperfusion model, as in the optic nerve crush model, elevated glutamate levels have been found in the vitreous, which led to the development of an excitotoxic model. In order to fully understand excitotoxic involvement in the pathogenesis of retinal ischemic injury, investigators created a model where rats were injected intravitreally with excitatory amino acids or their analogues (NMDA, kainate and AMPA) to induce RGC damage (Vorwerk et al., 1996) . At lower dose levels, a single intravitreal injection of NMDA can damage the ganglion cell layer and the inner plexiform layer without affecting the other retinal layers (Akaike, Adachi, & Kaneda, 1998) . Intravitreal glutamate injection demonstrated that excitotoxicity in the adult rat retina caused severe degenerative changes, which progressed in two stages: an initial stage of massive cellular swelling and a second stage of necrosis and cell loss. Degeneration involved ganglion and inner nuclear layer cells. Inner retinal thickness decreased concurrently. By two months post-injection, degenerative changes in rods and some loss of photoreceptor nuclei were also observed (Sisk & Kuwabara, 1985) .
Intravitreal NMDA injection led to the appearance of internucleosomal fragmentation of retinal DNA and of terminal transferase dUTP nick-end labeling (TUNEL)--positive nuclei in the inner retina. Ultrastructural features consistent with classic apoptotic changes were noted in degenerating cells in the RGC layer and the inner nuclear layer. Control retinas given vehicle or NMDA plus the glutamate receptor antagonist MK-801 did not show these changes. Simultaneous administration of NMDA and a caspase inhibitor also abolished or attenuated the loss of RGC in the retina. The conclusion was drawn that NMDA-induced excitotoxicity involved apoptosis and caspases in their pathways (Lam, Abler, Kwong, & Tso, 1999) . Morphometric analysis of retinal damage in NMDA-injected eyes also showed that BDNF, nipradilol, MK-801, or eliprodil could protect inner retinal cells. Furthermore, measurements of intravitreal glutamate levels indicated an increase in this excitatory amino acid in the vitreous after NMDA injection (Kapin et al., 1999; Kido et al., 2000; Mizuno, Koide, Yoshimura, & Araie, 2001; Morizane et al., 1997) . Another study revealed the upregulated expression of glial fibrillary acidic protein (GFAP) and ciliary neurotrophic factor (CNTF) in Muller cells in response to NMDA-induced neuronal death, suggesting that production of CNTF in Muller cells may be a part of the endogenous neuroprotective system in the retina .
Elevated levels of extracellular glutamate have been implicated in the pathophysiology of neuronal loss in central nervous system and ophthalmic disorders. A twofold elevation in the level of glutamate has been found in the vitreous body of patients with glaucoma undergoing cataract extraction when compared with that of a control population of patients with cataracts only. A similar elevation of glutamate level was found in the vitreous body of glaucomatous eyes of monkeys when compared with that in control eyes. The increased level of this transmitter is thought to be consistent with an ''excitotoxic'' mechanism for the RGC and optic nerve damage in glaucoma (Dreyer, Zurakowski, Schumer, Podos, & Lipton, 1996) . It is hypothesized that the increase in glutamate may result from a failure of the glutamate transporters. Nevertheless the excitotoxin injection model is self-fulfilling for damaging RGC by injecting a toxic dose of a substance, and thus may not fully represent glaucoma. Any neurological disease can be associated with an altered state of excitatory amino acid turnover/metabolism and therefore it seems unlikely that this would be a unique feature of glaucoma.
Induction of elevated IOP (vein occlusion, laser, S-antigen)
Elevated IOP is considered a primary risk factor for the initiation and progression of glaucomatous optic neuropathy (Leske, 1983) . Therefore the development of rodent models with surgically induced chronically elevated IOP to study the disease was a major aim. Due to the small size of mouse eyes, all induced models with elevated IOP have thus far been developed in the rat. Various approaches were devised to induce elevated IOP in the rat eye with the objective of impeding the outflow of aqueous humor. The most commonly used procedure is the cautery of two or three episcleral/limbal veins (Mittag et al., 2000; Shareef, Garcia-Valenzuela, Salierno, Walsh, & Sharma, 1995) or injection of hypertonic saline into limbal aqueous humor collecting veins (Moore, Milne, & Morrison, 1993; Morrison et al., 1997) . Other methods involve trabecular laser photocoagulation after injection of India ink into the AC or injection of S-antigen (Mermoud, Baerveldt, Mickler, Wu, & Rao, 1994) .
In both the cautery and the saline injection model an increased number of apoptotic RGCs was found (Garcia-Valenzuela, Johnson, Deppmeier, Wentzien, Hsu, & Morrison, 2000) . Also, the optic nerve head depletion of neurotrophins coincided with evidence of axonal degeneration, and loss of GFAP staining. Additionally an increase in soma diameter and expansion of dendritic fields in all types of RGCs in eyes with elevated IOP was described lately (Ahmed Farid, Chaudhary, & Sharma, 2001) .
Each of the aforementioned rat glaucoma models has advantages and disadvantages with its different level and length of time of IOP elevation. The S-antigen injection model has the advantage of a mean 75% IOP elevation lasting up to 20 days after induction. Nevertheless the massive inflammatory reaction with its anatomic sequelae of uveitis and the invasive intraocular procedure is its major weakness. The laser photocoagulation model has the advantage that the initial pathology is localized to the trabecular meshwork. However, peripheral anterior synechiae develop and multiple laser sessions are necessary to achieve 60% elevation of IOP. Hypertonic saline injection has the plus of impeding aqueous outflow close to Schlemm's canal. Potential disadvantages of this model are that multiple saline injections may be required, the level of IOP elevation is inconsistent for individual rats, and optic nerve damage does not show gradation or correlate completely with time and degree of IOP elevation. The vein cautery model has the advantage that it is technically easier than the two models discussed above and is said to give a more reliable longterm IOP elevation in groups of animals. The disadvantage of the method is that blood flow out of the eye is impeded by the occlusion of veins leaving the globe, which could cause obstruction in the intraocular vasculature. Thus, the elevation of IOP may be caused in part by the vascular congestion and by partial block of aqueous humor outflow. Although the retinal blood vessels appear normal by funduscopic examination (Neufeld, Sawada, & Becker, 1999; , it is uncertain to what degree retinal pathology may be affected by vascular congestion and/or decreased blood flow separate from the elevation of IOP in this model. The only study comparing the different induced IOP elevation models showed a pressure rise in 100% of the lasered eyes, a pressure elevation in 49% of the vein cautery eyes, and of 42% in the hypertonic saline model. In 83% of the lasered eyes there was optic nerve damage, which occurred in 36% of the saline injected eyes and only 20% of eyes in the cautery model (McKinnon et al., 1999) .
Spontaneous elevated IOP
Spontaneous occurrence of primary and secondary glaucoma has been described in some Wistar and Sprague-Dawley rats (Addison & How, 1926; Heywood, 1975; Young, Festing, & Barnett, 1974) . Nevertheless, to date no high-incidence-rate line could be bred for use in biomedical research.
In contrast, the DBA/2NNia, DBA/2J and AKXD-28/Ty inbred mouse strains have been found to spontaneously develop a form of secondary glaucoma (pigment dispersion) in almost 100% of the individuals (Anderson et al., 2001; John et al., 1998; Sheldon, Warbritton, Bucci, & Turturro, 1995) . Although the exact genetic defect responsible for all of these phenotypes has not been yet identified, it has been shown that recessive alleles at two loci, termed isa and ipd (chromosome 6 and 4) contribute to the anterior segment changes (Chang et al., 1999) . Pathologic studies indicate that the changes in these animals start at about 4 months of age with iris pigment epithelium loss and subsequent iris atrophy at 7 months leading to progressive closure of the angle and IOP elevation at 8-9 months of age (Pang et al., 1999) . This leads to a significant reduction of the RGC number and inner plexiform layer thickness at 14 months of age followed by optic nerve damage (Bayer et al., 2001; Williams, Strom, Rice, & Goldowitz, 1996) .
It seems that the mouse system, including the ability to alter specific genes, provides a powerful experimental system for drug studies, hypothesis testing, and genetic molecular dissection of the pathogenesis. The ability to control both genetic and environmental factors will allow the use of mice to identify genes that modify complex glaucoma phenotypes. By providing a bridge between gene identification and testing for gene function, mouse studies might become an important complement to glaucoma gene studies in humans and other species .
Summary
To date no spontaneous model for RGC damage in the rat is currently known and available for research.
The group of acute induced models in the rat includes the ischemia/reperfusion and the optic nerve crush models. The chronic group in the rat includes all models leading to an IOP elevation lasting for longer than 7 days. This has been achieved by cauterization of three episcleral veins, by injection of hypertonic saline in the episcleral veins, by injecting India ink into the AC, laser scarring of the trabecular meshwork, or by inducing a uveitic reaction through injection of S-antigen into the AC. An intermediate model, which can be regarded as chronic or acute, is multiple single injections respectively of glutamate or gangliotoxic substances (e.g. NMDA) into the vitreous humor. In contrast to the rat, there are mouse strains with spontaneous occurring ocular hypertension (secondary glaucoma) and consecutive ganglion cell damage/loss. The substrains identified are DBA/2NNia, DBA/2J and AKXD-28/Ty. Acute mouse models are similar to those in the rat, namely, the optic nerve crush and ischemia/reperfusion models. No chronic, induced mouse model as defined above is described to date but there is also an intermediate mouse model induced by injection of gangliotoxic substances into the vitreous humor.
Prospects
The main characteristic feature of glaucoma is the progressive and relatively slow damage/death of RGCs. As ganglion cell death is also a feature of a number of other optic neuropathies and retinopathies, the acute induced models which are useful in some aspects for glaucoma research can resemble more closely these other diseases than they do glaucoma. Examples of such a resemblance are TON in the case of the optic crush model and central artery occlusion in the case of the ischemia/reperfusion model. Therefore, the most relevant rodent glaucoma model should include chronic elevation of IOP. Due to the difficulty in reproducing a standardized chronic elevated IOP model thus far in the rat, a main focus of interest should be to discover rodent strains with spontaneously elevated IOP and to obtain as complete as possible an understanding of their retinal pathology.
